SHANGHAI RENDU BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 688193 for the last quarter is 47.42 M CNY, and it's 28.72% higher compared to the previous quarter. The net income of Q4 23 is 11.53 M CNY.